Loading clinical trials...
Loading clinical trials...
A Registry Study to Surveil Early Liver Injuries Caused by Xianlin Gubao Capsule (XLGB Capsule)
Conditions
Locations
1
China
302 Military Hospital
Beijing, Beijing Municipality, China
Start Date
March 25, 2017
Primary Completion Date
December 31, 2017
Completion Date
December 31, 2017
Last Updated
March 27, 2017
NCT06872372
NCT05517668
NCT05465642
NCT04553003
NCT04625166
NCT02182167
Lead Sponsor
Beijing 302 Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions